Epidemiology and genetic characterization of Shigella flexneri strains isolated from three paediatric populations in Egypt (2000-2004)

Epidemiology and Infection

Volumn 134, Issue 6, 2006, Pages 1237-1248

  Ahmed, S F ^a   Riddle, M S ^a   Wierzba, T F ^a   Abdel Messih, I A ^a   Monteville, M R ^a   Sanders, J W ^a   Klena, J D ^a,b  

^a US Naval Medical Research Unit No 3 Egypt   (Egypt)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ENTEROTOXIN; ERYTHROMYCIN; GENOMIC DNA; NALIDIXIC ACID; SHIGELLA VACCINE; TETRACYCLINE;

ANALYSIS OF VARIANCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEHYDRATION; DIARRHEA; DISEASE SURVEILLANCE; DNA ISOLATION; EGYPT; FEMALE; FEVER; GENE IDENTIFICATION; HEMATOCHEZIA; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MICROBIAL DIVERSITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRESCHOOL CHILD; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; SEROTYPING; SHIGELLA FLEXNERI; SHIGELLOSIS; UNINDEXED SEQUENCE;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; DATA COLLECTION; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; EGYPT; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROTOXINS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PHYLOGENY; SEROTYPING; SHIGELLA FLEXNERI;

EID: 33750317376     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026880600642X     Document Type: Article

References (48)

1. Kotloff KL, et al. Global burden of Shigella infections: Implications for vaccine development and implementation of control strategies. Bulletin of the World Health Organization 1999; 77: 651-666.
2. WHO. Vaccine research and development. New strategies for accelerating Shigella vaccine development. Weekly Epidemiological Record 1997; 72: 73-79.
3. Wehler T, Carlin NI. Structural and immunochemical studies of lipopolysaccharide from a new provisional serotype of Shigella flexneri. European Journal of Biochemistry 1988; 176: 471-476.
4. Carlin NIA, et al. Use of monoclonal antibodies to type Shigella flexneri in Bangladesh. Journal of Clinical Microbiology 1989; 27: 1163-1166.
5. Coimbra RS, Grimont F, Grimout PAD. Identification of Shigella serotypes by restriction of amplified O-antigen gene cluster. Research Microbiology 1999; 150: 543-553.
6. Talukder KA, et al. 2001. Altering trends in the dominance of Shigella flexneri serotypes and emergence of serologically atypical S. flexneri strains in Dhaka, Bangladesh. Journal of Clinical Microbiology; 39: 3757-3759.
7. Vasilev V, et al. Variability of Shigella flexneri serotypes in Israel during a period of two years: 2000 and 2001. Epidemiology and Infection 2004; 132: 51-56.
8. El-Gendy A, et al. Identification of Shigella flexneri subserotype 1c in rural Egypt. Journal of Clinical Microbiology 1999; 37: 873-874.
9. Talukder KA, et al. Phenotypic and genotypic characterization of provisional serotype Shigella flexneri 1c and clonal relationships with 1a and 1b strains isolated from Bangladesh. Journal of Clinical Microbiology 2003; 41: 110-117.
10. MoezArdalan K, et al. Prevalence and pattern of antimicrobial resistance of Shigella species among patients with acute diarrhoea in Jaraj, Tehran, Iran. Journal of Health, Population and Nutrition 2003; 21: 96-102.
11. Nguyen TV, et al. Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam. Antimicrobial Agents and Chemotherapy 2005; 49: 816-819.
12. Özmert E, et al. Shigella antibiotic resistance in Central Turkey: comparison of the years 1987-1994 and 1995-2002. Journal of Pediatric Gastroenterology and Nutrition 2005; 40: 359-362.
13. Wasfy MO, et al. Isolation and antibiotic susceptibility of Salmonella, Shigella, and Campylobacter from acute enteric infections in Egypt. Journal of Health, Population and Nutrition 2000; 18: 33-38.
14. Green S, Tillotson G. Use of ciprofloxacin in developing countries. Pediatric Infectious Disease Journal 1997; 16: 150-159.
15. Jick S. Ciprofloxacin safety in a pediatric population. Pediatric Infectious Disease Journal 1997; 16: 130-133.
16. WHO. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae 1 (http://whqlibdoc.who.int/publications/2005/ 9241592330.pdf). Accessed 1 March 2006.
17. Putnam SD, et al. Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea. Diagnostic Microbiology and Infectious Disease 2003; 47: 601-608.
18. Putnam SD, et al. Antimicrobial susceptibility trends among Escherichia coli and Shigella spp isolated from rural Egyptian paediatric populations with diarrhoea between 1995 and 2000. Clinical Microbiology and Infection 2004; 10: 804-810.
19. Wasfy MO, et al. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clinical Infectious Diseases 2002; 35: 1265-1268.
20. Vasilev V, et al. Antimicrobial resistance of Shigella flexneri serotypes in Israel during a period of three years: 2000-2002. Epidemiology and Infection 2004; 132: 1049-1054.
21. Nataro JP, et al. Identification and cloning of a novel plasmid-encoded enterotoxin and enteroinvasive Escherichia coli and Shigella strains. Infection and Immunity 1995; 63: 4721-4728.
22. Talukder KA, et al. Phenotypic and genotypic characterization of serologically atypical strains of Shigella flexneri Type 4 isolated in Dhaka, Bangladesh. Journal of Clinical Microbiology 2002; 40: 2490-2497.
23. Noriega FR, et al. Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes. Journal of Infectious Diseases 1995; 172: 1408-1410.
24. Venkatesan MM, Buysee JM, Kopecko DJ. Use of Shigella flexneri ipaC and ipaH gene sequences for the general identification of Shigella spp and enteroinvasive Escherichia coli. Journal of Clinical Microbiology 1989; 27: 2687-2691.
25. Niyogi SK, Vargas M, Vila J. Prevalence of the sat, set and sen genes among diverse serotypes of Shigella flexneri strains isolated from patients with acute diarrhoea. Clinical Microbiology and Infection 2004; 10: 574-576.
26. Vargas M, et al. Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea. Journal of Clinical Microbiology 1999; 37: 3608-3611.
27. Abdel-Messih I, et al. Diarrhea associated with Cryptosporidium parvum among young children on the Nile River Delta in Egypt. Journal of Tropical Pediatrics 2005; 51: 154-159.
28. Rao MR, et al. Pathogenicity and convalescent excretion of Campylobacter in rural Egyptian children. American Journal of Epidemiology 2001; 154: 166-173.
29. Wierzba TF, et al. Clinic-based surveillance for bacterial- and rotavirus-associated diarrhea in Egyptian children. American Journal of Tropical Medicine and Hygiene 2006; 74: 148-153.
30. WMO. Workbook on management and prevention of diarrhoea, vol. WHO/CDR/ 95.7, 1997.
31. CLSI. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement M100-S15. Clinical and Laboratory Standards Institute, 2005.
32. Hunter SB, et al. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: Converting the national databases to the new size standard. Journal of Clinical Microbiology 2005; 43: 1045-1050.
33. Yavzori M, Cohen D, Orr N. Prevalence of the genes for shigella enterotoxins 1 and 2 among clinical isolates of shigella in Israel. Epidemiology and Infection 2002; 128: 533-535.
34. Sethabutr O, et al. Detection of PCR products of the ipaH gene from Shigella and enteroinvasive Escherichia coli by enzyme linked immunosorbent assay. Diagnostic Microbiology and Infectious Disease 2000; 37: 11-16.
35. Jones ME, et al. Widespread occurrence of integrons causing multiple antibiotic resistances in bacteria. Lancet 1997; 349: 1742-1743.
36. Sin LK, et al. β-lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel OXA-1-like β-lactamase, OXA-30. Antimicrobial Agents and Chemotherapy 2000; 44: 2034-2038.
37. Fullá N, et al. Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semi-rural community in the northern administrative area of Santiago, Chile. American Journal of Tropical Medicine and Hygiene 2005; 72: 851-854.
38. Pazhani GP, et al. Species diversity and antimicrobial resistance of Shigella spp isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India. Epidemiology and Infection 2005; 133: 1089-1095.
39. Zafar A, Sabir N, Bhutta ZA. Frequency of isolation of Shigella serogroups/serotypes and their antimicrobial susceptibility pattern, in children from, slum areas in Karachi. Journal of the Pakistan Medical Association 2005; 55: 184-188.
40. Ashkenazi S, et al. Growing antimicrobial resistance of Shigella isolates. Journal of Antimicrobial Chemotherapy 2003; 51: 427-429.
41. Abu-Elyazeed R, et al. Epidemiology of Shigella-associated diarrhea in rural Egyptian children. American Journal of Tropical Medicine and Hygiene 2004; 71: 367-372.
42. Dutta S, et al. Shifting serotypes, plasmid profile analysis and antimicrobial resistance pattern of shigellae strains isolated from Kolkata, India during 1995-2000. Epidemiology and Infection 2002; 129: 235-243.
43. Pupo GM, Lan R, Reeves PR. Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics. Proceedings of the National Academy of Sciences USA 2000; 97: 10567-10572.
44. Noriega FR, et al. Strategy for cross-protection among Shigella flexneri serotypes. Infection and Immunity 1999; 67: 782-788.
45. Simmon DA, Romanovska E. Structure and biology of Shigella flexneri O antigens. Journal of Medical Microbiology 1987; 23: 289-302.
46. Van de Verg LL, et al. Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection. Vaccine 1996; 14: 1062-1068.
47. Bii CC, et al. Detection of virulence-related genes by multiplex PCR in multidrug-resistant diarrhoeagenic Escherichia coli isolates from Kenya and Japan. Epidemiology and Infection 2005; 133: 627-633.
48. Mølbak K. Human health consequences of anti-microbial drug-resistant Salmonella and other foorborne pathogens. Clinical Infectious Diseases 2005; 41: 1631-1640.